Position in PAHC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,683,448
-$1,850,750 QoQ
Shares Held
53,613
-16.1% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 207 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. PAHC ranks #26 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in PAHC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,683,448 | 53,613 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,534,198 | 63,898 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,425,112 | 64,912 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,735,460 | 67,609 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,821,614 | 71,324 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,573,740 | 73,677 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,608,222 | 76,582 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,713,726 | 76,098 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,362,176 | 81,227 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,044,575 | 80,787 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $961,904 | 83,066 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $985,473 | 77,171 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,022,910 | 74,665 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,018,213 | 66,463 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $844,374 | 62,966 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $839,050 | 63,134 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,171,042 | 61,215 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,241,209 | 62,216 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,191,282 | 58,339 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,264,333 | 58,697 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,836,450 | 63,589 | Shares | Sole | 2021-08-05 | |
| 2020-12-31 | $1,304,169 | 67,156 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,049,446 | 60,313 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,666,227 | 63,427 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,622,121 | 67,113 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||